Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Nature Communications
|
December 5, 2023
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening
Azucena Ramos, Catherine E Koch, Yunpeng Liu-Lupo, et al.
Nature Medicine
|
September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
Nicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Nature
|
September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma
Nelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Marc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Nature Communications
|
December 5, 2023
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening
Azucena Ramos, Catherine E Koch, Yunpeng Liu-Lupo, et al.
Nature Medicine
|
September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
Nicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Nature
|
September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma
Nelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Marc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Page
of 3